Claritas Pharmaceuticals, Inc.
OTC: CLAZF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Farrell
- Employees
- 3
- Headquarters
- San Rafael, United States
- IPO year
- 2016
- Market cap
- $3.7K
- Website
- https://claritaspharma.com
Loading CLAZF…
Loading profile data…Frequently asked questions about CLAZF
What does Claritas Pharmaceuticals, Inc. (CLAZF) do?
Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Clar...
Where does CLAZF trade?
Claritas Pharmaceuticals, Inc. (CLAZF) trades on the Other OTC.
What sector is CLAZF in?
Claritas Pharmaceuticals, Inc. (CLAZF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Claritas Pharmaceuticals, Inc.?
Robert Farrell is the chief executive officer of Claritas Pharmaceuticals, Inc. (CLAZF).
Where is Claritas Pharmaceuticals, Inc. headquartered?
Claritas Pharmaceuticals, Inc. is headquartered in United States.
Does CLAZF pay a dividend?
Claritas Pharmaceuticals, Inc. (CLAZF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CLAZF go public?
Claritas Pharmaceuticals, Inc. (CLAZF) completed its initial public offering in 2016.